Complete Response Letter Received for AVT02 Biologics License Application
Teva plant tagged with warning letter for issues making schizophrenia drug | Fierce Pharma
Teva months from restarting production at Hungary plant banned by US FDA
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Filling errors, counterfeit packs gain FDA's attention | Packaging World
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Surprise US FDA inspections: Cause for alarm? | Mint
FDA Warning Letter To Teva Highlights Need For Accurate Root Cause Investigations :: Pink Sheet
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Stops Production At US Plant After FDA Concerns: Report
Teva recalls US-made drugs following contamination fears - The Boston Globe
Cheap Prescription Drugs in U.S. Can Have Hidden Cost - Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Site Inspections | Teva api
Celltrion FDA warning causes headache for Teva's biologics ambition
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens
FDA warning letter says Teva China plant has more work to do on API issues | Fierce Pharma
FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan | Radio Compass Blog
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
FDA Scorecard: Drug Shortages and Inspections - DCAT Value Chain Insights
Teva Pharma Suspends Irvine Production After FDA Probe - Orange County Business Journal
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | Fierce Pharma
Teva Pharmaceutical Works Private Limited Company 10/13/16
